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Human B-cell differentiation has been extensively investigated on genomic and
transcriptomic grounds; however, no studies have accomplished so far detailed
analysis of antigen-dependent maturation-associated human B-cell populations from a
proteomic perspective. Here, we investigate for the first time the quantitative proteomic
profiles of B-cells undergoing antigen-dependent maturation using a label-free LC-MS/
MS approach applied on 5 purified B-cell subpopulations (naive, centroblasts,
centrocytes, memory and plasma B-cells) from human tonsils (data are available via
ProteomeXchange with identifier PXD006191). Our results revealed that the actual
differences among these B-cell subpopulations are a combination of expression of a
few maturation stage-specific proteins within each B-cell subset and maturation-
associated changes in relative protein expression levels, which are related with
metabolic regulation. The considerable overlap of the proteome of the 5 studied B-cell
subsets strengthens the key role of the regulation of the stoichiometry of molecules
associated with metabolic regulation and programming, among other signaling cascades
(such as antigen recognition and presentation and cell survival) crucial for the transition
between each B-cell maturation stage.
Keywords: B-cell differentiation, naive B cell, centroblast, centrocyte, memory B cell, quantitative proteomics,
transcriptomics integrationorg March 2021 | Volume 12 | Article 6378321
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The final stages of antigen-dependent human B-cell
differentiation leading to (oligo)clonal B-cell expansion and
affinity maturation are associated with activation of naive B-
cells to their terminal differentiation into antibody-secreting
plasma cells (PC) and memory B-cells, in secondary lymphoid
tissues (SLT) such as tonsils (1). To initiate this highly dynamic
and strictly regulated process, immature B lymphocytes leave the
bone marrow and migrate via the peripheral blood (PB) to the
spleen for maturation into naive B cells, which can then travel to
the germinal centers (GC) of SLTs (2, 3). The antigen-dependent
maturation starts with the presentation of protein antigens to
helper T cells and the production of cytokines. Then, a broad
antibody repertoire can be generated in developing B cells by
means of somatic recombination. In order to increase the affinity
and avidity of antibodies, an affinity maturation process occurs
as a result of somatic hypermutation of immunoglobulin (Ig)
genes in B cells, giving rise to the selection of strongly binding B
cell receptors (BCR) (Supplementary Figure S1A) (3, 4).
Within the GC, the dark zone—where proliferation and
somatic hypermutation occur—hosts the centroblasts (CB),
which further differentiate into smaller centrocytes (CC) that
enter the light zone of the GC. Both GC B-cell populations
display a considerable overlap in their gene expression profiles,
despite showing a clearly distinct morphological appearance
(4, 5).
The specific molecular pathway, leading to the generation of
memory B-cells following the GC reaction still remain largely
unclear (5, 6). Most likely, different factors, such as the affinity of
the BCR and the CD40 and CD40L signaling are key elements
involved in this process (6). Thus, Smith et al. (7) have proposed a
model for memory selection in which memory B-cells and PC are
formed from different GC driving pathways, and Scheeren et al.
revealed the role of STAT5 in the regulation of memory B-cell
differentiation (6). In addition, Kulis et al. (8) through the analysis of
the DNA methylome of 5 maturation-associated subpopulations of
B-cells (pre-BII cells, naive B- cells, GC B-cells, memory B-cells and
PC) showed a dynamic CpG methylation pattern during B-cell
maturation, where memory B-cells and bone marrow PC showed
the lowest methylation levels.
In recent years, several studies have investigated the genomic,
epigenetic and transcriptomic profiles along normal B-cell
differentiation (9–15). In turn, most data generated so far
about the proteomic profile of B-cells at distinct differentiation
stages has been derived from the study of cell lines at different
time points after in vitro stimulation (e.g. anti-sIgM,
lipopolysaccharide) using classical (16, 17) and innovative (18,
19) proteomic strategies. To the best of our knowledge, only one
proteomic study (20) analyzed SLT-derived primary GC cells to
investigate the similarities between the proteome of mantle cellAbbreviations: Ag, Antigen; BCR, B-cell receptor; CB, Centroblasts; CC,
Centrocytes; FDR, False discovery rate; GC, Germinal centers; Igs,
Immunoglobulins; MCL, Mantle cell lymphoma; M, Memory B-cell; N, Naive
B-cell; PC, Plasma cells; PCA, Principal component analysis; PB, Peripheral blood;
RT, Room temperature; SLT, Secondary lymphoid tissues; SHM, Through
somatic hypermutation.
Frontiers in Immunology | www.frontiersin.org 2lymphoma (MCL) cells and normal GC cells. However, the
quantitative proteome of SLT-derived non-tumoral human
primary B-cells along antigen-dependent B-cell maturation
(from naive B-cells to PC and memory B-cells) has not been
described so far.
Identification of aberrant protein profiles (related to the
splicesome, proteasome, phagosome, HLA molecules, protein
synthesis and stability) associated with physiological and
pathological conditions such as aging, cancer, auto-immunity,
allergy or immunodeficiency is of key relevance for the
understanding of the underlying mechanisms involved since
proteins are the biochemical effectors in virtually all cellular
processes (21). Therefore, the analysis of the proteome of the
normal B-cell counterpart of e.g. tumoral B-cells becomes a
critical step.
Here, the role of multiple metabolic pathways at different
stages of antigen (Ag)-dependent maturation is revealed from
the overall (quantitative) global proteome of non-tumoral B-cell
populations at different stages of Ag-dependent maturation from
naive B-cells to recently generated PCs and memory B-cells from
primary non-tumoral tonsils. Furthermore, we integrated the
proteomics data set with publicly available transcriptomic data
sets to provide a better view and understanding of the normal B-
cell maturation process triggered by recognition, and to create a
reference map for the identification of altered B-cell-associated
protein expression profiles during life and in specific
disease conditions.MATERIALS AND METHODS
Sample Collection
Freshly collected human tonsils were obtained from 5 donors
(see Table 1) after routine tonsillectomies. In cases A, B, C, and
D, tonsils were removed due to more than seven documented
throat infections in the year preceding the surgery. In case E,
tonsillectomy was performed to improve obstructive sleep apnea.
In all cases, informed consent was given by the donor according
to the guidelines of the local ethics committee of the University
Hospital of Salamanca, in accordance with the Helsinki
Declaration of 1975, as revised in 2008.
Single tonsil cell suspensions were obtained (immediately after
surgery) by using conventional mechanical disaggregation
procedures (3) in PBS. A minimum of 150 x 106 tonsil cells
were stained in parallel in several different tubes (15 min at room
temperature (RT) in the darkness) with the following 8-color
combination panel of monoclonal antibodies: CD45 conjugated
with fluorescein isothiocyanate (CD45-FITC), CD184 conjugated
with phycoerythrin (CD184-PE), CD38 conjugated with peridinin
chlorophyll protein-Cy5.5 (CD38-PerCPCy5.5), CD10 conjugated
with PE- Cy7 (CD10-PECy7), CD20 and CD19 conjugated with
APC (CD20-APC, CD19-APC), CD3 conjugated with
allophycocyanine-H7 (CD3-APCH7), and CD27 conjugated
with Brilliant Violet™ 421 (CD27-BV421) (22). Then, B-cell
populations were systematically sorted by FACSAria (BD) at 4°
C (cell population gating strategy shown in Supplementary
Figure S2, sorting purity values shown in Table 1) based on theMarch 2021 | Volume 12 | Article 637832
Dı́ez et al. B-Cell Differentiation From A Proteomics Perspectivefollowing phenotypes: naive B-cells (CD45+, CD184-, CD38-,
CD10-, CD19/CD20+, CD3-, CD27-), centroblasts (CD45+,
CD184+, CD38+, CD10+, CD19/CD20+, CD3-, CD27het),
centrocytes (CD45+, CD184-, CD38+, CD10+, CD19/CD20+,
CD3-, CD27het), memory B-cells (CD45+, CD184-, CD38-,
CD10-, CD19/CD20+, CD3-, CD27+), and plasma cells (CD45+,
CD184-, CD38++, CD10+, CD19/CD20+, CD3-, CD27++) (3).
Purified cells were immediately processed for protein extraction.
Protein Extraction
Each cell population (naive B-cells, CB, CC, memory B-cells, and
PC) was washed three times with PBS (5 min, 1500 g). After
draining off the total PBS volume without disturbing the cell
pellet, the lysis buffer (9 M urea, 1 mM activated sodium
orthovanadate, 2.5 mM sodium pyrophosphate, 1 mM b-
glycerol phosphate, 20 mM HEPES pH 8.0) was added to the
cell pellet (15 mL per 1 x 106 cells), followed by sonication on ice
(3 bursts of 15 seconds each). Then, samples were centrifuged at
maximum speed for 15 min and the supernatant containing the
proteins was collected at -80°C until further processing.
Protein Quantification and SDS-PAGE
Proteins were quantified using the DC™ Protein Assay Kit II, as
recommended by the manufacturer. A total of 15 mg of proteins from
naive B-cell, CB, CC and memory B-cell samples were separated on a
4-20% gradient SDS-PAGE gel. After electrophoresis, gels were
stained in a solution of 0.5% (w/v) Coomassie Brilliant Blue and
stored at 4°C in an aqueous solution containing 1% (v/v) acetic acid,
until analysis. PC protein samples were processed in solution.
In-Gel and In-Solution Protein Digestion
Two protein digestion approaches were performed due to PC
sample limitations. Proteins from naïve B-cells, CB, CC, and
memory B-cells were digested in gel, whereas proteins from PC
were digested in solution since the amount of sample was not
enough (high difficulty in isolating PC from tonsils due to their
low relative numbers) to be processed in the gel. For in-gel
protein digestion, each gel lane was cut into five fragments and
digested with trypsin following the method of Shevchenko et al.
(23) with slight modifications. Briefly, gel pieces were destained
with 50% acetonitrile (ACN) and 50 mM ammoniumFrontiers in Immunology | www.frontiersin.org 3bicarbonate. Protein reduction and alkylation were performed
with 10 mM dithiothreitol (DTT) at 56°C for 45 min, and with 55
mM iodoacetamide at RT for 30 min, respectively. Proteins were
digested with trypsin (6.25 ng/mL) at 37°C for 18 h. The peptide
solution was acidified with 0.1% trifluoroacetic acid and desalted
by using C18-Stage-Tips columns (24). The samples were
partially dried and stored at −20°C until analysis by LC-MS/
MS. For in-solution protein digestion, a total of 4 mg of protein
from PC were reduced with 10 mM DTT at RT for 45 min and
alkylated as previously indicated. Proteins were then digested
with trypsin (1:50 w/w) at 37°C for 18 h and the peptide solution
was processed as done for in-gel protein digestion.
LC-MS/MS Analysis
A nanoUPLC system (nanoAcquity, Waters Corp., Milford, MA)
coupled to a LTQ Orbitrap XL mass spectrometer (Thermo
Fisher Scientific, San Jose, CA) via a nanoelectrospray ion source
(Proxeon Biosystems) was used for reversed-phase LC-MS/MS
analysis. Peptides were loaded onto a trapping column
(Symmetry 300 C18 UPLC Trap Column, 180 mm × 20 mm,
5 mm, Waters Corp.). Peptides were separated on a BEH130 C18
column 75 mm × 200 mm, 1.7 mm (Waters Corp.) equilibrated in
3% ACN and 0.1% formic acid with a linear gradient of 3% to
50% ACN at a flow rate of 300 nL/min over 140 min for in-gel
digested proteins (naive B-cell, CB, CC, memory B-cell samples),
and 170 min for in-solution digested proteins (PC samples). The
nUPLC- LTQ Orbitrap XL was operated in the positive ion mode
by applying a data-dependent automatic switch between survey
MS scan and tandem mass spectra (MS/MS) acquisition. Survey
scans were acquired in the mass range of m/z 400 to 2000 with a
30 000 resolution at m/z 400. The 6 most intense ions with states
of 2 and 3 were selected in the ion trap for fragmentation by
collision-induced dissociation with normalized energy. Dynamic
exclusion was enabled for 30 s.
Gene Expression Microarrays
Data from the expression profiling of FACS-sorted B-cell subsets
from 6 human tonsils on Affymetrix Human Exon 1.0 ST arrays
were downloaded from the NCBI’s Gene Expression Omnibus
dataset (accession code GSE69033). Raw data was processed as
described below.TABLE 1 | Tonsil sample characteristics.
Tonsil Sex Agea (years) Diagnosis Tonsil-purified cellsb (x 106) [%purity]
N CB CC M PC
I M 6 Sleep apnea 6.9 [95%] 10.4 [95%] 8.5 [95%] 10.5 [90%] 1.7 [75%]
II F 4 Tonsillitis 15.0 [98%] 13.0 [95%] 16.8 [99.9%] 12.8 [95%] 1.1 [85%]
III F 26 Tonsillitis 5.7 [98%] 2.1 [98%] 2.1 [99.5%] 4.4 [98%] <0.1 [91%]
IV F 20 Tonsillitis 5.2 [93%] 5.5 [96%] 4.5 [99%] 3.3 [93%] <0.1 [70%]
V F 17 Tonsillitis 8.0 [98%] 3.0 [93%] 8.9 [99%] 8.3 [97%] <0.1 [82%]March 2021 | Volume 12 | ArtaAge at time of surgery.
bBy FACS-Aria sorting (Becton/Dickinson Biosciences, San José, CA).
M, male; F, female; N, naive B-cell; CB, centroblast; CC, centrocyte; M, memory B-cell; PC, plasma cell.
The sex and age of the patients, as well as the diagnosis for tonsil surgery, are indicated. Additionally, the number of total purified cells from each tonsil sample is depicted together with the
purity percentage of the sorted cells.icle 637832
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Full downstream analysis was done employing a homemade
custom program, using R v.3.4 (25) in the RStudio suite (26)
(Supplementary File 1).
Qualitative Protein Expression Profiles
A binary heatmap of absence-presence was generated in order to
compare all populations and analyze which patterns were shared
by the different replicates. For each population, functional and
pathway analyses via over-representation tests were done using
the clusterProfiler package (27).
Quantitative Protein Expression Levels
Due to protein retrieval constraints, only four populations (CB,
CC, naive, and memory subsets) could be compared for
quantitative protein expression levels. Using the Progenesis
suite, an ANOVA test with a q-value cutoff of 0.05 followed up
by individual T-tests was used to determinate which proteins
discriminated among different cell populations. The
corresponding heatmap was generated by normalizing each
protein by its own z-score among them. Absent proteins in a
sample were considered to have zero expression. Hierarchical
dendrograms using Euclidean distances were employed for
clustering both genes and cell populations.
Transcriptomics Analyses
To operate with the gene expression profiling and analysis of the
different populations of B-cells, the gene expression results of the
GSE69033 (13) data set, including six biological replicates of each
population, were selected. The mRNA of these cells was
hybridized on an Affymetrix Human Exon 1.0 ST Array high-
density oligonucleotide microarray. For each gene, an ANOVA
test was performed followed by a Bonferroni p-value correction,
and those genes with a p-value lower than 0.05 were investigated
by a Tukey HSD test with the same cutoff, to determinate which
populations could be distinguished.
Integration of Proteomics and
Transcriptomics Datasets
Our proteomics and transcriptomics datasets come from different
samples and subjects. To address this issue, a proteomics set and a
transcriptomics set for each population were generated including
the mean value for each protein or transcript present in all replicates
(Supplementary File 1). To determine the expression patterns
using both data sets, three Circos track plots (28) were generated.
Each Circos plot contained line tracks with the quantitative
information of the four comparable cell populations; one Circos
plot had information of the log10 of our proteomics data (only
proteins present in all 5 replicates), the second one for the log10 of
the transcriptomic data (only transcripts whose proteins were
present in all 6 replicates), and the last one contained the
information of the log10 of the direct ratio between the
proteomics and transcriptomics datasets. The results of the earlier
mentioned ANOVA tests and follow-up tests were represented in
attribute plots (29). At the same time, protein/transcript ratios were
represented as a heatmap, scaling each ID by its own z-score.Frontiers in Immunology | www.frontiersin.org 4Populations were clustered via hierarchical dendrograms, using
Euclidean distance, while ratios were clustered in four groups
using density based clustering of applications with noise clustering
via the dbscan package (30). ID conversion and coordinate retrieval
were done using the biomaRt package (31, 32).
Quantification Analysis Using Progenesis
Progenesis QI for proteomics v3.0 software (Nonlinear
Dynamics, Quayside, Newcastle Upon Tyne, UK) was used for
quantification of the multiplexed LC-MduriS data. We compared
the B-cell populations by analyzing 5 biological replicates.
Specifically, for in-gel digested samples, the Progenesis LC-MS
fractionation workflow was performed analyzing 5 fractions
from each sample (each fraction corresponded to each band
gel sliced during the gel processing). For sample alignment, the
sensitivity was set to 5 and MS spectra with intensities > 500
0000, and ions with charges 2-7 were considered for the filtering
process. Normalization was applied automatically to all features.
Peptide identification was performed using Mascot Search
engine (Matrix Science, London, UK) on Proteome Discoverer
1.4. software (Thermo) by searching against the neXtProt
database (release December 20, 2016), including the common
contaminant sequences (e.g., human keratins, trypsin, BSA).
Search parameters were set as follows: carbamidomethylation
of cysteine as a fixed modification, oxidation of methionine and
acetylation of the protein N-terminus as variable ones, precursor
and fragment mass tolerances were set to 10 ppm and 0.6 Da,
respectively, and fully tryptic digestion with up to two missed
cleavages. False discovery rate (FDR) was set at 1%. Peptide
results were imported into the Progenesis QI software, for
quantitative analysis and statistical evaluation. Identified
peptides were refined removing identifications with a score less
than 30, sequence length less than 6 and not human proteins.
Peptides assigned to more than one protein were considered
conflicting and resolved according to Progenesis guidelines. For
reporting peptides and proteins, ANOVA (p ≤ 0.05) and max
fold change (≥2) values were calculated.RESULTS
Mapping Ag-Dependent B-Cell
Differentiation via Characterization of the
Global Proteome of Tonsillar B-Cells at
Different Maturation Stages
Qualitative evaluation of the global proteome of human B-cells at
different stages of maturation was performed on purified naive
B-cells, CB, CC, memory B-cells, and PC from 5 primary human
tonsils (Table 1) as described in the “Materials and Methods”
section (Supplementary Figure S1).
Only those proteins that were identified in all B-cell
subpopulation replicates of the 5 tonsil samples were
considered for further analyses. Overall, similar numbers of
distinct proteins were identified for all B-cell subsets analyzed
(a total of 1,992 proteins were identified on naive B-cells, 2,472
on CB, 2,548 on CC, and 2,567 on memory B-cells) except for PCMarch 2021 | Volume 12 | Article 637832
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amount obtained from the purified PC samples vs the other 4 B-
cell subpopulations (median of 4 vs 15 mg of protein,
respectively), due to the very low frequency of PC in tonsils
(Supplementary Table S1; Figure 1). A more detailed analysis of
the distribution of these proteins revealed an overlap of 350
proteins among the 5 B-cell subpopulations, up to 1,547 proteins
being shared by naive B-cells, CB, CC and memory B-cells (in-gel
processed subsets) (Supplementary Figure S1).
The binary heatmap in Supplementary Figure S3 illustrates
the clustering of tonsil B-cell subsets based on the presence/
absence of proteins (qualitative proteomics characterization).
Thus, two main groups were observed; group 1 included only
the PC while group 2 included naive B-cells, CB, CC, and
memory B-cells. Since such clustering was mainly due to the
limited amount of sample processed for PC as discussed above,
we further investigated the differences in protein expression
profiles of the cell populations included in the second group.
Such analysis showed that, among the 4 B-cell populations in the
second group, naive B-cells were those showing a clearly distinct
proteome, with clearly lower numbers of proteins identified, and
suggesting that the overall number of proteins expressed
increases as B-cell differentiation progresses from naive to
memory B-cells. Of note, proteins exclusively expressed in GC
B-cells (33) (Supplementary Table S2), mostly included proteins
involved in DNA and RNA synthesis (RNA polymerase, MED21;
RNA helicase, DDX47; DNA replication complex, GINS3;
transcription, GTF2A2; translation, EIF4G2; initiation factors;
nuclear pore glycoprotein, NUP62; and histone, HIST2H2BC).
In turn, the proteins expressed solely in GC B- cells (i.e. CB and
CC) laid in the expression of 24 of 2,472 (1%) specific proteins
(Figure 1; Supplementary Table S2) in CB (proteins affecting B-
cell receptor signaling such as VAV1, VAV2, GTPase
RAP1GDS1; proteins involved in transcription process and
histone acetylation such as BRD2 and in cell apoptosis processFrontiers in Immunology | www.frontiersin.org 5such as FADD) and 50 of 2,548 (2%) in CC (Figure 1;
Supplementary Table S2) (e.g. NR3C1, BCL7A, PEG10,
RGS13). Likewise, the investigation of naive B-cells displayed 7
of 1,992 (0.4%) proteins uniquely identified in this cellular subset
(RNASEH2C, MRPL21, PURB, NDUFA3, HBQ1, PCBD2, and
C9orf64) (Figure 1; Supplementary Table S2). Interestingly, the
expression of specific proteins may determine the fate of the B-
cells from the GC to differentiate into memory B-cells or PC. The
qualitative comparison of the protein profiles of both
subpopulations (i.e. memory B-cells and PC) (Supplementary
Table S1) displayed that 29 proteins of the PC proteome were
not expressed by memory B-cells, 25 of 393 (6%) of them were
exclusively expressed in PC. These 29 PC-specific proteins
included specific Ig molecules (IGKV3-11, IGKV3-15, IGHD,
IGLC3, and JCHAIN), cytochrome C oxidases (COX6B1,
COX7C), regulatory and transcription factors (IRF4, GTF2A1,
LZTFL1), and the Abl interactor (ABL1) among other proteins.
In addition, two of the remaining proteins were detected in both
cell subsets but in different isoforms - isoform 1 (memory B-
cells) and isoforms 5 and 2 (PC) for ADAR and PRKCAB
proteins, respectively-. In contrast, 48 of 2,567 (2%) proteins
were exclusively expressed by memory B- cells and not detected
in PC (Supplementary Table S2), including the EBF1, BCL2L13,
LRBA, IRF9, ITGB1, NMI, MRPL55, and THEMIS2 proteins.
Quantitative Maturation-Associated
Protein Profiles From Naive to GC
and Memory B-Cells
For quantitative protein analyses, a restriction criterion was
established when a protein presented a value=0 for ≥1 of the 5
sample replicates investigated within each B-cell subpopulation;
in such case, a value=0 was also assigned to the other replicates
for that subpopulation (i.e. following the criteria established
above for the qualitative analysis). However, the protein was
not removed from the analysis as 0 has a quantitative meaningFIGURE 1 | Attribute plot displaying the qualitative proteomic analysis of the 5 B-cell subpopulations (naive B-cells, centroblasts, centrocytes, memory B-cells, and
plasma cells). Each column indicates unique protein numbers and corresponds to either a unique population (violet-, orange-, red-, blue- and green-filled dots for
centrocytes, memory B cells, plasma cells, centroblasts and naïve B cells, respectively) or a set of populations (black- and brown-filled intersected dots). The bar
chart on the bottom left side plots the total number of proteins identified per B-cell population. * The proteomics processing of plasma cells was different due to
sample limitations.March 2021 | Volume 12 | Article 637832
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was “absent” across all B-cell populations analyzed, that protein
was removed from further analyses. Thus, only differentially
expressed proteins (ANOVA p-value<0.05) were included in the
quantitative analysis for a total of 753 proteins expressed at
significantly different levels (p-value<0.05) among the distinct B-
cell subsets (Supplementary Table S3). Of note, due to the
limited protein amount of PC protein samples, this B-cell
subpopulation was not included in the quantitative proteome
analyses that were thereby, exclusively performed on naive B-
cells, CB, CC, and memory B-cells.
The quantitative proteomics data collected in Supplementary
Table S3 was the basis for the principal component analysis
(PCA) shown in Supplementary Figure S4, which revealed
grouping of the B-cell subpopulations according to the relative
protein abundances with a clearly higher separation between
naive B-cells and the other three B-cell populations. In turn, CB
and CC clustered closely together, while memory B-cells
appeared to be closer to naive B-cells.
The distribution of the 753 differentially expressed proteins
across the distinct human chromosomes and the different B-cell
subpopulations are depicted in Supplementary Figure S5
(panels A, B, C). Of note, highly similar protein expression
patterns were detected at the chromosome level for the GC andFrontiers in Immunology | www.frontiersin.org 6memory B-cells in contrast to naive B-cells, the latter showing
lower expression levels for specific proteins encoded on
chromosomes 1-4, 6, 8-9, 11, 14-15, 22 and X. Regarding the
remaining chromosomes, protein expression profiles were
similar among the four maturation-associated B-cell subsets
analyzed, except for chromosome 11, for which naive B-cells
and CB on one side, and CC and memory B-cells on the other
side, were closer to each other.
Figure 2 depicts a hierarchical clustering analysis of the levels
of these proteins differentially expressed among the distinct B-
cell populations (naive B-cells, CB, CC, memory B-cells) (n=753)
for each tonsil (1–5) sample analyzed. Overall, a high similarity
was observed for all samples between CB and CC on one side,
and to a less extent also, between naive and memory B-cells on
the other side (except for two outliers, M5 and CB2). As
discussed already above, this quantitative heatmap (together
with that of Supplementary Figure S3) showed that the lowest
protein expression values corresponded to the naive B-cells
(coded as blue, Z-score values<0) whereas the highest ones
corresponded to both CC and CB (coded as orange and red,
respectively; Z-score values ≥2). Protein expression profiles of
memory B-cells were more heterogeneous, including proteins
presenting high expression levels and others being absent or
expressed at low levels.FIGURE 2 | Heatmap based on Z-score values for the proteins identified and quantitatively measured in naive B-cells (N), centroblasts (CB), centrocytes (CC) and
memory B-cells (M). The color gradually changed from 4 (red) to 1 (yellow) and -2 (blue).March 2021 | Volume 12 | Article 637832
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the highest expression levels was as follows: 363 of 753 (48%)
proteins were most strongly expressed in CB; 271 of 753 (36%) in
CC; 97 of 753 (13%) in memory B-cells; and 22 of 753 (3%) were
most strongly expressed in naive B-cells (as illustrated in
Supplementary Figure S6). Conversely, the lowest expression
levels for most proteins corresponded to the less differentiated
cells (naive B-cells) - 608 of 753 (81%) proteins -, followed by
memory B-cells – 92 of 753 (12%) -, and both CC and CB – 29 of
753 (4%) and 24 of 753 (3%) -, respectively (Supplementary
Table S3).
Pairwise comparisons (1 vs 1) between the different B-cell
subsets (Supplementary Table S3) showed (summarized results
in Supplementary Table S4 and Supplementary Figure S7)
proteins with significantly different relative abundances between
each pair of B-cell populations (p-value<0.05). Once again, naive
B-cells were those with lower numbers of proteins being over-
expressed (<10% of all differentially expressed proteins). Of note,
CB and CC showed a homogeneous distribution (60-40%,
respectively) indicating the great similarity between both B-cell
populations. Additionally, proteins associated with memory B-
cells were found to be under-expressed in all pair-wise
comparisons, except vs naive B-cells.
Functional Evaluation of the Differential
Protein Profiles Identified Across Different
Maturation-Associated B-Cell Populations
Functional enrichment screening for those proteins differentially
expressed across the distinct B-cell populations in the 5 tonsil
samples analyzed (Supplementary Table S5) revealed that those
350 proteins which were systematically detected in all B-cell
subsets (Supplementary Table S1) were annotated in 56
functional clusters highly enriched in general cell functions
(e.g. actin and tubulin binding, biosynthesis, proteolysis, cell-
cell adhesion, RNA processing and glucose metabolism).
Further analyses of the functional pathways associated with
the individual B-cell subsets (Supplementary Figure S8;
Supplementary Table S5) showed that proteins that were
exclusively identified in naive B-cells participated in a few
pathways (e.g. ribosome, metabolic pathways, and DNA
replication) also common to the other B-cell subsets. In turn,
memory B-cell proteins were related to a greater number of
pathways, particularly the protein processing (i.e. synthesis,
PTMs, stability, degradation), antigen processing and
presentation, and JAK-STAT signaling pathways. Specific
proteins expressed by CB and CC were related to Fc-gamma-
R-mediated phagocytosis and chemokine signaling pathways. In
turn, CB and memory subsets shared (specific) proteins
belonging to the Toll-like receptor, TGF-beta, WNT, cAMP,
IL17, Fc epsilon R, TNF and cell cycle signaling pathways.
Likewise, the ERBB, PI3K-AKT, MAPK, and mTOR signaling
pathways included proteins exclusively identified on CC and
memory B-cells. Regarding PC-specific proteins, these were
mostly involved in protein export, spliceosome, and metabolic
pathways. Overall, the EGFR tyrosine kinase inhibitor resistance,
DNA replication, MAPK signaling, antigen processing andFrontiers in Immunology | www.frontiersin.org 7presentation, ribosome, protein export, spliceosome and
metabolic pathways were those most differentially represented
across the naive, CB, CC, memory and PC proteomes.
Protein enrichment within these networks revealed the more
significant modules (Supplementary Figure S9A, Supplementary
Table S6) and pathways (Supplementary Figure S9B,
Supplementary Table S6) involved. Thus, the module with a
greater number of genes/proteins detected in all B-cell
subpopulations related to ribosome/protein synthesis, also
associated with the spliceosome network in the pathway analysis.
Of note, the citrate cycle was the most significant pathway in PC.
Quantitative Protein Differences During
B-Cell Differentiation
The variation in the (quantitative) levels of specific proteins
throughout the four maturation-associated B-cell populations
analyzed (i.e. naive B-cells, CB, CC, memory B-cells) provided
interesting insights into the B-cell differentiation process.
Relevant protein groups for B-cell development, functioning
and survival are depicted in Figure 3 and listed below.
Findings are further explained in the Discussion section.
HLA proteins, responsible for the regulation of the immune
system. In general, HLA-A proteins showed an increased
expression in CB and memory B-cells with decreased values
(even absent) in naive B-cells and CC. HLA-A-1 was significantly
over-expressed in memory B-cells. Regarding HLA-B proteins,
their expression progressively increased with higher B-cell
differentiation from naive to memory B-cells, except for HLA-
B-44. In turn, the HLA-DP, HLA-DQ and HLA-DR proteins
showed a similar expression pattern, with a transient reduction
in CB followed by a progressive recovery up to the memory B-cell
subset; HLA-DOA displayed significantly higher expression
levels in naive and memory B-cells.
Ig, serving as antigen receptors or neutralizing agents against
specific antigens. Concerning Ig, no significant differences were
observed for the IGHV as well as IGHM proteins. However,
IGHA and IGHG1 displayed higher expression levels in GC B-
cells (i.e. CB and CC). Regarding the Ig kappa/lambda light
chains, the greatest differences among B-cell subsets were
observed for the IGLL5 protein whose expression levels were
decreased in CB and memory B-cells, while increased in naive B-
cells and CC.
14-3-3 proteins, playing an isoform-specific role in class switch
recombination. The expression profile of 14-3-3 proteins was
constant across all 4 B-cell populations with higher levels in GC
B-cells (CB and CC), and lower levels in naive and memory
B-cells.
Caspases, for cell cycle regulation. Caspases and caspase-
related proteins showed an unequal distribution along B-cell
differentiation: some of these proteins showed low levels in CB
and CC (CARD16, CASP14), another displayed increasing
expression levels from naive to memory B-cells (CARD11),
and another one had clear higher expression levels in the
CB (CASP3).
B-cell associated proteins and adhesion molecules. The
expression of these membrane proteins was characterized byMarch 2021 | Volume 12 | Article 637832






































FIGURE 3 | Expression of specific groups of proteins across the different maturation-associated B-cell populations analyzed. The mean intensity obtained in
each B-cell population was calculated and represented by family groups. N, naive B-cells; CB, centroblasts; CC, centrocytes; M, memory B-cells.
Dı́ez et al. B-Cell Differentiation From A Proteomics Perspectiveeither high levels in CB and memory subsets (CD20, CD81,
CD53, CD180) or uniform expression levels across all 4 B-cell
subsets with a slight increase among naive B-cells (CD22,
CD44, CD79B).
FAS-associated proteins, involved in apoptosis. Interestingly,
Fas-associated proteins were absent in naive B-cells (FADD,
FAF1, FAF2, PARP14, TRADD), except for TRAF3IP3 and
TNFAIP8, which presented the highest levels in this B-cell
subset. For the TRADD and PARP14 proteins, memory B-cells
were those showing the highest expression values.
Transcription factors (TF). Expression of TF was increased in
GC B-cells (CB and CC) compared to naive and memory B-cells,
both as regards the nuclear and overall TFs identified to be
positively expressed. The same distribution pattern was found for
the AP-1 proteins.
ATP synthase proteins, to catalyze the cell energy production. No
significant differences were observed for these proteins among
naive, CB, CC and memory B-cells, except for ATP5O, which
almost doubled its expression in CC (vs. naïve andmemory B-cells).
“Missing Proteins” and their patterns across B-cell
subpopulations. The Human Proteome Project (HPP) has
identified a set of proteins called “missing proteins” in based the
reported evidence of these proteins (34). These missing proteins are
classified by HPP in 5 groups called PE1 (evidence at protein level),
PE2 (evidence at transcript level), PE3 (inferred from homology),
PE4 (predicted), PE5 (uncertain). Then, complementary study to
quantitative protein expression levels was evidence of protein
existence (PE) classification (way to classify the so-called “Missing
Proteins”). Here, it is explored only from the protein datasets (mean
protein expression value) which identified protein candidates on
groups PE1, PE2, PE5. Thus, 606 proteins have been correlated with
a transcriptomics counterpart in the expression microarray, where
599 are include in PE1, one in PE2 and 6 in PE5. In the case of PE2
protein, RGS13 (with evidence at transcript level) is involved in
signal transduction; while the six proteins (NCF1B, HSP90AB3P,
HIST2HBC, SNX29P2, RPL0P6, POTEKP) in group PE5 are
involved in stress response, DNA-binding, phosphatidylinositol
binding, ribosomal protein and ATP binding (Supplementary
Table S7). Within this group of PE5 proteins, the proteins
HSP90AB3P, HIST2HBC and RPLP0P6, related with DNA-
binding, stress response and ribosomal functions, show a
differential protein profile during B-cell differentiation, where low
levels are observed in naive B-cells and memory B-cells and
progressive level expression increase is depicted for CB, whereas
for CC there is a progressive decrease. Regarding the proteins
NCF1B and SNX29P2, which are phosphatidylinositol binding
proteins, present a similar pattern a similar profile, with
progressive increasing of its expression level from naive B-cells to
CC, and low levels in memory B-cells. Finally, POTEKP presents a
completely different pattern from the other ones, with low levels in
naive B-cell, increasing pattern in CB and memory B-cell and
decrease profile in CC (Supplementary Figure S10).
Other proteins. IL16, LSP1, MZB1, SERPINB1, BCAP31, and
BCL2L13 showed higher expression levels on memory B-cells vs
all other subsets. In contrast, the highest expression levels for
TCL1A were found in naive B-cells, gradually decreasing downFrontiers in Immunology | www.frontiersin.org 9to the memory B-cells compartment. Also, BCL2L2 presented
the lowest expression levels among naive B-cells whereas the
highest ones were detected in CB, CC and, particularly memory
B-cells. EBF1 was expressed at slightly higher levels in CC vs CB,
with the highest levels being observed on memory B-cells. In
turn, REL, EZH2, and BAX presented the lowest expression
levels in naive B-cells and high expression levels in CB.
Regarding the expression level of BCL2, the memory subset
displayed the highest values of the quantitative expression.
Correlation Between the Transcriptome
and the Proteome of Distinct Maturation-
Associated B-Cell Populations
The results of previously reported transcriptomics analyses,
performed on the same maturation-associated B-cell
populations, following identical processing and purification
strategies (13), were compared with our proteomics results. A
total of 6 tonsils were analyzed for transcriptomics and the
resulting values (after processing transcriptomics data) were
averaged as performed also for the proteomics data of this study.
First, the global list of genes contained in the transcriptomics
platform, together with the differentially expressed genes
(Supplementary Table S8) and their correspondence to
differentially expressed proteins (ANOVA p-value<0.05)
detected by LC-MS/MS was integrated and evaluated. Results
of such comparative analyses (Supplementary Figure S7A)
revealed a greater number of molecules differentially expressed
by transcriptomics than those detected in the proteomics analysis
(Supplementary Figure S7B), which could have been expected
due to the total genome coverage of the transcriptomics platform
vs the quantitative proteomics dataset. Thus, only 6% (201 of
3,241) of those transcripts that were found to be differentially
expressed were associated also with a significantly differentially
expressed (translated) protein. Additionally, a greater number of
differentially expressed genes between naive B-cells and GC B-
cells was found (2,826 of 3,241 genes; 87%). By contrast, naive
and memory B-cells were more similar at the transcriptomic
level showing only 450 of 3,241 (14%) genes differentially
expressed between them. As done for the proteomics dataset, a
representative cluster plot was generated to evaluate the
distribution of the genes expressed in the different B-cell
populations per chromosome (Supplementary Figure S5B).
To evaluate the correlation between transcriptomics and
proteomics datasets for the different B- cell populations analyzed
(naive, CB, CC, and memory), an updated version of the R-script
tool previously described by our group (35) for integrating both
sets of data was used. After calculating the corresponding ratios
between proteomics and transcriptomics expression values
(Supplementary Table S9), the results revealed higher protein/
transcript ratios for CB, CC andmemory B-cells than for the naive
B-cells (Figure 4). A total of 569 paired genes/proteins were
present in both datasets and therefore compared (expressed
genes not detected by the proteomics approach were not
included in this correlation analysis, Supplementary Table S8).
This hierarchical clustering analysis (Figure 4) revealed two main
groups of cells: group 1 consisting of naive and memory B-cells;March 2021 | Volume 12 | Article 637832
Dı́ez et al. B-Cell Differentiation From A Proteomics Perspectiveand group 2, that included GC (CB and CC) B-cells. These data are
also represented in Supplementary Figure S5C displaying the
differences among the distinct B-cell subpopulations at the gene/
protein levels per chromosome (i.e. protein-encoding genes in
chromosomes 1, 4-6, 9, 15-16, 19, 22). Also, Supplementary Table
S10 and Supplementary Figure S11 display five major protein
clusters (obtained after self-organizing map (SOM) analysis from
data collected in Supplementary Table S3) representing once
more the protein expression dynamics across the distinct B-cell
subpopulations. For example: SRSF2 and PDIA4 proteins from
cluster 1 displayed higher gene/protein ratios at CC population,
whereas proteins from cluster 5 (TRAF3IP3, CPOX, TPK1,
S100A6, DCTD, LGMN) depicted lower ratio levels in the
same population.Frontiers in Immunology | www.frontiersin.org 10Evaluation of the Expression of Proteins
Specific for One or More Maturation-
Associated B-Cell Populations by Multi-
color Flow Cytometry (FCM)
The expression patterns of a subset of 11 differentially expressed
proteins across the 4 B-cell populations analyzed (i.e. naive B-
cells, CB, CC, and memory B-cells) was also quantitatively
evaluated by FCM on the B-cell surface membrane (CD20,
CD22, CD44, CD45, CD54, CD71, CD74, CD79B, CD81, and
CD98) or at the intracellular levels also TCL1A. Overall, highly
similar expression patterns were found for around half of these
proteins (511; 45%) (Supplementary Figure S12): CD44, CD54,
CD71, CD74, and TCL1A. Of note, FCM analysis confirmed our
previous results about the expression levels of the TCL1AFIGURE 4 | Correlation between the proteomics and transcriptomics datasets for the distinct maturation-associated B-cell populations analyzed. The figure depicts
a total of 569 genes/proteins detected by both approaches and the corresponding hierarchical clustering analysis for the 4 B-cell subpopulations (naive B-cells,
centroblast, centrocyte and memory B-cells) investigated. Z-score values assuming the differences of proteomics/transcriptomics correlations are color-coded (blue
for low P/T ratios and red for high P/T ratios). Lists of genes/proteins, as well as the ratio values, are shown in Supplementary Table S9.March 2021 | Volume 12 | Article 637832
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from naive to GC and memory B-cells.DISCUSSION
Human B-cell differentiation has been extensively investigated on
genomics and transcriptomics grounds (12, 15, 35), providing
relevant data about those genes (and their modifications) and
transcripts that regulate B-cell differentiation. Nevertheless, no
studies have addressed so far, a detailed analysis of cells at
different Ag-dependent human B-cell maturation stages from a
quantitative and differential intracellular signaling proteomic
perspective. Despite genomic information is highly relevant to
understand the molecular basis of B-cell differentiation, the
dynamics of this process can only be fully understood by also
exploring and integrating the corresponding transcriptome and
proteome information for each maturation stage (33, 34, 36, 37).
Specifically, the main level of information required to understand
the functioning of cells is the global analysis of proteins (i.e. key
functional components of the cell) (38). However, the
accomplishment of this examination is complex due to the
amino acids features, the protein modifications and degradation,
and the intricate and variable signaling networks in which proteins
are involved (37).
Here, the quantitative proteomic profiles of human B-cells
undergoing Ag-dependent maturation in tonsils have been
described, depicting the intracellular pathways involved and the
correlation with transcriptomics data. Thus, 5 different B-cell
subpopulations at distinct stages of maturation (naive B-cells, CB,
CC, memory B-cells, and PC) were highly purified from 5 human
tonsils and proteomics-profiled by using a label-free quantitative
LC-MS/MS approach. Qualitative analyses were performed on all 5
B-cell subsets, providing insights into their proteome maps that
contributed to the understanding of how each B-cell subset gives
rise to the next one. Quantitative proteomics comparisons shed
further light on those differentially significantly expressed proteins,
which may influence the switch among the studied B-cell
maturation stages. Overall, our results showed a high overlap of
the proteome of the 5 B-cell populations. Focusing on naive B-cells,
CB, CC and memory B-cells, which were processed in a fully
comparable way, this overlapping involved up to 1,897 proteins,
which constituted 95% of proteins expressed by naive B-cells and
~75% of proteins detected in CB, CC, and memory B-cells. As
might be expected, these proteins were typically involved in general
cell functions such as actin and tubulin binding, biosynthesis,
proteolysis, cell-cell adhesion, RNA processing and glucose
metabolism. Despite the high intersection among the proteomes
of B-cells at different maturation stages, specific proteins were also
identified within each B-cell subset. Thus, GC-specific proteins
included MED21, DDX47, GINS3, GTF2A2, EIF4G2, NUP62,
and HIST2HBC, found in both the CB and CC proteomes, which
are associated with FC-gamma-R-mediated phagocytosis and
chemokine signaling pathways. In turn, while CB expressed
VAV1, VAV2, RAP1GDS1, BRD2, and FADD among other
proteins, CC exclusively expressed NR3C1, BCL7A, PEG10, andFrontiers in Immunology | www.frontiersin.org 11RGS13 within a total group of 50 unique proteins in the absence of
the above listed CB-specific proteins. Of note, RGS13, whose
expression was restricted to CC, has an important role in
chemotaxis and the limitation of the expansion of GC cells (39).
In turn, the expression of the VAV1/2 proteins restricted to CB is
crucial for PC development and secretory Ig production (40),
suggesting that PC might originate from a subset of CB-cells that
up-regulate VAV1 and VAV2 expression leading to the induction
of PC formation. In turn, naive B-cells presented only 7 exclusive
proteins (i.e. RNASEH2C, MRPL21, PURB, NDUFA3, HBQ1,
PCBD2 and C9orf64) involved in ribosome formation, metabolic
pathways, and DNA replication.
At present, the precise proteins that are associated with
differentiation of GC B-cells to memory B-cells vs PC still
remain largely to be identified (41). Overall, our results showed
29 PC-specific proteins that were not identified in paired
memory B-cells. These proteins were related to Ig (IGKV3-11,
IGKV3-15, IGHD, IGLC3 and JCHAIN), cytochrome C oxidases
(COX6B1, COX7C), regulatory and transcription factors (IRF4,
GTF2A1, LZTFL1), and the Abl interactor ABL1. From these
proteins, IRF4 has been claimed to define Ig-secreting PC by De
Silva et al. (4, 42), being its expression associated with protein
networks related to protein export, the spliceosome, and
metabolic pathways among which the citric acid cycle network
is the most significant. This, together with increased expression
of cytochrome C oxidases in PC vs GC and memory B-cells
might reflect the high energy consumption of PC, probably
required because of their high Ig-secreting functionality. In
parallel, high expression of multiple transcription factors
discloses a unique increase in gene expression in these cells
affecting previously silenced genes (i.e. a new transcriptional cell
program). Finally, overexpression of ABL1 confirms previous
observations by Li et al. (43) which revealed the role of this
tyrosine kinase on PC survival.
In turn, the EBF1, BCL2L13, LRBA, IRF9, ITGB1, NMI,
MRPL55 and THEMIS2 proteins were exclusively expressed in
memory B-cells. Among others, these memory B-cells linked
proteins involved in metabolic pathways, antigen processing and
presentation, and the JAK-STAT signaling pathway. Thus, LRBA
promotes proliferation, clonal expansion and cell survival of
antibody-secreting cells and its deficiency has been demonstrated
to reduce proliferation (44, 45). In turn, high levels of ITGB1
(also known as CD29) have been detected in memory B-cells
(46). Of note, THEMIS2 was exclusively identified in the
memory B-cell compartment, despite it seems to be not
required for B-cell development (47).
Overall, naive B-cells emerged as the less differentiated cells of
all B-cell subsets analyzed as for its protein expression profile
strongly overlapped with that of the other B-cell populations,
which showed greater proteomic diversity. However, qualitative
differences existed for only a limited number of all expressed
proteins. In contrast, more differentially expressed proteins were
identified when the relative quantity of each protein across the
distinct B-cell differentiation stages was considered. Additionally,
quantitative analysis depicted 753 proteins to be differentially
expressed in naïve B-cells, CB, CC, and memory B-cells.March 2021 | Volume 12 | Article 637832
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patterns were found for CB and CC on one side, and for naive
and memory B-cells on the other side, with the lowest protein
expression values being detected in naive B-cells further
supporting their less differentiated nature. In contrast, the
highest levels of protein expression were found for GC B-cells
depicting the high functionality and protein turnover
characteristic of these cells (2). Subsequent pair-wise
comparisons between each B-cell population and both the
previous and/or subsequent maturation stages confirmed the
highly similar and homogeneous (quantitative) proteomics
profile of CB and CC (2). By contrast, proteins of naive B-cells
were under-expressed vs all other maturation stages.
More detailed analysis of those specific protein groups
differentially expressed across the different maturation-
associated B-cell populations revealed new insights into their
functional proteomics throughout B-cell maturation. Thus, for
the HLA-associated proteins, significantly high expression levels
of HLA-DO were found in naive and memory B-cells vs GC cells,
confirming previous observations by others studies (2, 48). In
contrast, expression of the HLA-DR and CD74 molecules was
higher within GC cells compared with the other two B-cell
populations. These results support those of Chalouni et al.
suggesting that when a specific Ag encounters naive B-cells,
synthesis of new HLA II molecules is initiated to favor CB
selection (48). Within the HLA I, expression of HLA-A and
HLA-B proteins progressively increased as the B-cell maturation
process advanced, except for HLA-B44, which would support the
greater endogenous Ag-peptide presenting capacity of long-lived
PC and memory B-cells vs short-lived naive B-cells. Regarding Ig
molecules, two main expression patterns were observed: i) no
differences among the B-cell subsets were found for IGHM and
IGHV, while ii) greater expression values were found for IGHA,
IGHG, Igl, Igk in GC B-cells vs both naive and memory B
lymphocytes. Whereas the production of the mu and variable
heavy chains of the Ig starts in the bone marrow, production of
IgG and IgA requires class switch recombination in the GC,
which likely explains our observations (49). In line with these
findings, the 14-3-3 proteins involved in class-switch
recombination expressed also significantly higher levels in CB
and CC B-cells as also previously demonstrated by Xu et al. (50).
Interestingly, a relatively high number of differentially
expressed proteins play distinct roles in apoptosis and/or
survival of B-cells. For instance the CARD11 scaffold protein
showed increasing levels from naive B-cells (lacking CARD11
expression) to memory B-cells, this protein being altered in a
spectrum of diffuse large B-cell lymphomas (DLBCL) (51),
mainly those derived from GC (GCB-DLBCL) and activated B-
cells (ABC-DLBCL) (52), where it plays a key role in activating
the NF-kB pathway to induce the B-cell proliferation and the
proliferation vs death checkpoint in activated B-cells (52).
TRADD also activates this pathway (53) and it was found to
be overexpressed in memory B-cells vs less differentiated mature
B-cells; which may be very interesting from a pathogenic point of
view. Conversely, CASP3, a key regulator of Fas-mediated cell
death in mature peripheral B-cells (54), was highly expressed inFrontiers in Immunology | www.frontiersin.org 12GC cells, particularly in CB (55). Of note, most Fas-related
proteins were missing in naive B-cells, which might be due to
the need of these cells to expand for continuing their B-cell
differentiation and ensuring antibody production.
Study of missing proteins patterns shows expression profiles
in accordance with the processes that occur along the cellular
differentiation of the B-lymphocyte. High levels of DNA binding
protein in CB are related to mutation for function receptor
generation and cell proliferation, and this type of proteins
decreases its levels as B cells differentiate into CC and memory
B-cells. A similar pattern was observed for stress response and
ribosomal proteins, since CB presented high expression levels
due to the changing environment in which they are found.
Regarding phosphatidylinositol binding protein, high levels
were observed in CC, correlating with the active cell signaling
due to antigen presentation required at this differentiation stage.
Finally, ATP-binding protein presented a higher relative
expression in memory B-cells compared to others, which
correlated with the vesicle transport processes occurring in the
immune synapse for antigen presentation in MHC molecules to
T lymphocyte (56–61). Regarding other B-cell related proteins,
distinct differentiation-associated profiles were observed. Thus,
while CD22, CD44, and CD79B showed similar expression
values throughout the B-cell maturation, other markers such as
TCL1A, CD20, CD53, CD81 and CD80 varied substantially.
Accordingly, expression of TCL1A was detected at the highest
levels in the first stages of maturation (e.g. naive B-cells), it was
reduced upon GC development and silenced in long-lived
memory B-cells, as previously shown also by others (62). In
contrast, IL16 protein levels peaked in memory B-cells and the
highest CD20, CD53, CD81, and CD180 protein amounts were
observed in CB and memory B-cells. Of note, expression of
CD20 correlated with the expression of both HLA-A and HLA–B
molecules, and CD81, which could reflect the well-known role of
CD20-HLA-I and CD20-CD81 interactions required for the
regulation of cell cycle progression in B-cells (63). Similarly,
NFKB1 and NFKB2, two proteins that play an important role in
B-cell activation and GC formation, were both detected at higher
levels in CB and CC vs naive and memory B-cells (4). In turn,
BCL2 was highly expressed in memory B-cells, supporting its
role in the development and survival of the long-lived B-cell
subset. In line with these observations, the expression of the BAX
and BID pro-apoptotic proteins was higher in CB vs both naive
and memory B-cells, respectively (64). Finally, the expression of
EZH2 was increased in both CB and CC GC B-cells, their levels
decreasing thereafter when the cells leave the GC (4).
In summary, our results provide a first map of the proteome of
Ag-dependent B-cell maturation in tonsils supporting the value of
quantitative proteomics data, which provides more information
than that of qualitative proteomics solely based on the presence vs
absence of the proteins. In addition, we show that along the
differentiation of mature B-cells, the naive B-cell compartment
typically shows expression of fewer proteins usually at lower levels,
most of which are shared by the immature GC andmemory B-cells.
Of note, a highly similar proteomics profile was found for CB and
CC while memory B-cells more closely mimicked naive B-cellsMarch 2021 | Volume 12 | Article 637832
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Supplementary Table 1 | Qualitative results. The lists of identified proteins are
shown for each B-cell subpopulation (naive B-cells, N (sheet 1); centroblasts, CB
(sheet 2); centrocytes, CC (sheet 3); memory B-cells, M (sheet 4); plasma cells, PC
(sheet 5)) including the protein identifier (Uniprot ID), complete name of the protein
(description), abundance values for each B-cell subpopulation and replicate (1-5),
and mean value. The sheet 6 contains the lists of proteins in common among B-cell
subpopulations and the unique proteins per group resulting from a Venn analysis.
Supplementary Table 2 | Unique proteins identified per B-cell subpopulation.
Lists of proteins (gene name) exclusively identified in the indicated B-cell
subpopulation are shown.Frontiers in Immunology | www.frontiersin.org 13Supplementary Table 3 | Quantitative analysis. The lists of proteins of the
quantitative analysis are depicted (sheet 1) together with the 1-to-1 comparisons
(sheets 2-7). The UniProt ID (accession), the number of detected peptides per
protein (peptide count), the number of unique peptides per protein (unique
peptides), the confidence score, the ANOVA p-value (ANOVA (p)), the max fold
change, the B-cell population with the highest mean for each protein (highest mean
condition), the B-cell population with the lowest mean for each protein (lowest mean
condition), the complete name of the protein (description), and the normalized
abundance for each replicate within each B-cell population are indicated. The
significant proteins (ANOVA p-value < 0.05) detected after pair-wise comparisons of
B-cell subpopulations. 1 means “significant differences”, 0 means “no significant
differences” (sheet 8).
Supplementary Table 4 | Quantitative protein results after comparing B-cell
subpopulations with each other. The total number of significantly expressed
proteins within each comparison is depicted as well as the number and percentage
of proteins highly expressed in one subpopulation compared to the other one.
Supplementary Table 5 | Functional enrichment analysis (FEA) of the proteins
identified in the 5 B-cell subpopulations. The file contains 5 Tables with the
annotated clusters (p-value<0.05): (I) Table “350 in common” shows the 56
annotated clusters identified for the proteins in common across the naïve (N), CB,
CC, memory (M), and PC subsets. (II) Table “1547_N_CB_CC_M” includes the 129
annotated clusters identified for the proteins in common across N, CB, CC, and M
subsets. (III) Table “419_CB_CC_M” displays the 63 annotated clusters for proteins
in common in CB, CC, and M subsets. (IV) Table “77_CC_M” shows the two
annotated clusters for proteins in common between CC and M subpopulations. (V)
Table “25_PC” depicts the two annotated clusters identified for the 25 proteins
exclusively detected in the PC subset. (VI) Lists of proteins identified within each B-
cell subpopulation across the pathways represented in Supplementary Figure S8.
Supplementary Table 6 | Significantly enriched modules and pathways related
to the 5 B-cell subpopulations. The file contains 2 Tables: (I) Table “Modules” shows
the different modules per B-cell subpopulation and the corresponding p-value, q-
value and adjusted p-value, as well as the GeneName and GeneSymbol of the
genes included in the module. (II) Table “Pathways” shows the same information as
stated above for the pathways.
Supplementary Table 7 | Data set missing proteins detected by MS/MS.
Information on missing proteins detected after proteomic analyses in progress of B-
lymphocyte differentiation during antigen-dependent phase.
Supplementary Table 8 | Transcriptomic data. The file contains: (I) the results of
the expression profiling of B-cell subsets sorted from human tonsils on Affymetrix
Human Exon 1.0 ST arrays (raw data deposited at NCBI’s Gene Expression
Omnibus database, GSE69033) after calculating the mean expression values (6
biological replicates) for each B-cell subset (naive B-cells, centroblasts, centrocytes,
memory B-cells and plasma cells). The presence/absence of each gene displayed
on the array in the proteomic analysis is also indicated. (II) The significant genes
(ANOVA p-value < 0.05) detected after pair-wise comparisons of B-cell
subpopulations. 1 means “significant differences”, 0 means “no significant
differences”. (III) Lists of proteins, genes and their combination which have shown
significant differences in the ANOVA test (p-value<0.05).
Supplementary Table 9 | Proteomics/transcriptomics ratios. The correlation
between both strategies was calculated according to the mean values for each
gene/protein within each B-cell subpopulation. (I) Proteomics mean values for the
606 proteins having a transcriptomic counterpart in the expression microarray. (II)
Proteomics/transcriptomics ratios for the 569 genes/proteins presenting values in
both datasets.
Supplementary Table 10 | Data set Proteomic clusters. Protein clusters were
built by applying a hierarchical self-organizing map (SOM) algorithm and including
Gene Ontology information. Each protein value was calculated as the mean protein
expression in each B-cell population. Graphs showing these data are represented in
Supplementary Figure S11.March 2021 | Volume 12 | Article 637832
Dı́ez et al. B-Cell Differentiation From A Proteomics PerspectiveSupplementary Figure 1 | Proteomic workflow performed on B-cells. Panel (A)
shows the B-cell ontogeny from the hematopoietic stem cell (HSC) to the long-lived
B-cell populations. Panel (B) depicts the procedure followed to process the
proteins from naive B-cells (N), centroblasts (CB), centrocytes (CC), memory B-cells
(M) and plasma cells (PC) for further mass spectrometric (MS) analysis after in-
solution and in-gel protein digestions.
Supplementary Figure 2 | Gating strategy used for the classification of tonsilar
B-cell populations. In a first step, total B-cells were subsequently gated as FSClow/
SSClow, CD19+/CD20+/CD45+ and CD3- (pink dots) (A). In a second step (B),
these gated B-cells were dissected into 5 subpopulations based on their staining
profile for CD10, CD27, CD38, and CD184. CC: Centrocytes. CB: Centroblasts.
MBC, Memory B-cells. PC, Plasma cells.
Supplementary Figure 3 | Binary heatmap based on the presence/absence of
the proteins identified in the B-cell subpopulations. The blue color represents the
absence of a protein whereas the red color means presence.
Supplementary Figure 4 | Principal component analysis (PCA) graphics of B-cell
subpopulation comparisons after quantitative analysis of the identified proteins. The
quantitative proteomics data used for this PCA is collected in Supplementary
Table S3.
Supplementary Figure 5 | Circular graphical representation of differentially
expressed proteins (A), genes (B) and the corresponding proteomics/
transcriptomics ratios (C). Each graphic has four layers. From the outer layer to the
inner one, data for memory B-cells (orange), centrocytes (purple), centroblasts
(blue) and naive (green) B-cells are represented. Each layer depicts the quantitative
values for each protein within each chromosome. Remarkable proteins within the
dataset are indicated in the graphic. Since it is difficult to read such protein names in
the graphics, they are also mentioned here (in clockwise direction, same proteins/
genes for panels A–C): THEMIS2, CD53, RGS13, TRAF3IP3 (chromosome 1); REL,
XPO1, SF3B1 (chromosome 2); NFKB1 (chromosome 4); MZB1, CD74
(chromosome 5); HLA-B(x6), NFKBIE (chromosome 6); EZH2 (chromosome 7);
LYN (chromosome 8); VIM, GDI1 (chromosome 10); CD44, MS4A1, CASP1
(chromosome 11); GAPDH (chromosome 12); TCL1A, HSP90AA1 (chromosome
14); GINS3, PSMD7, IRF8 (chromosome 16); STAT3 (chromosome 17); VAV1,
DNMT1, VASP (chromosome 19); BID, MYH9 (chromosome 22).
Supplementary Figure 6 | Diagram representation of stacked deviations of
proteins identified and quantitatively measured in the B-cell subpopulations (naive
B-cells, centroblasts, centrocytes, memory B-cells). The number of proteins that
were differentially expressed, according to an outlier statistic, were calculated and
represented in intervals of Z-distance from the mean.
Supplementary Figure 7 | Attribute plots of pair-wise comparisons of (A)
proteins (data connected to Supplementary Tables S3 and S4) and (B) genes
(data connected to Supplementary Table S8) differentially expressed (ANOVA p-
value < 0.05) across the B-cell subpopulations. Set size refers to the total number of
proteins (A) or genes (B) present in each pair of populations (e.g. almost 600Frontiers in Immunology | www.frontiersin.org 14proteins in common for CC and M). Intersection size depicts the number of proteins
or genes in common for the paired populations only (orange, brown, pink, grey,
black and yellow for CC-M, CB-M, N-CC, N-CB, CB-CC and N-M, respectively) or
their combinations (bars in dark grey, combinations of paired-populations indicated
by black dots connected by black lines in the bottom part of the graph). The bigger
the intersection size, the more proteins/genes detected in those paired-populations
or combinations of paired-populations. N, naive B-cells; M, memory B-cells; CB,
centroblasts; CC, centrocytes.
Supplementary Figure 8 | Graphical visualization of the protein involvement in
signaling pathways. Bars length represents the total number of proteins contained
in the given pathways: in green (proteins of naive B-cells), blue (proteins of
centroblasts), light purple (proteins of centrocytes), light orange (proteins of memory
B-cells), red (proteins of plasma cells), and brown (proteins in common). The related
lists of proteins are collected in Supplementary Table S5.
Supplementary Figure 9 | Significantly enriched modules and pathways. Panel
(A) shows the modules detected as significantly enriched across the 5 B-cell
subpopulations. Panel (B) displays the significantly enriched pathways. The size of
the dots correlates with the number of genes identified in the corresponding B-cell
population belonging to the referenced module. The adjusted p-value is color-
coded from 0.01 and 0.004 (red) to 0.04 and 0.016 (blue) for modules (panel A) and
pathways (panel B), respectively. s.p., signaling pathway.
Supplementary Figure 10 | Mean protein expression pattern of missing proteins
detected for MS/MS in B-cell populations. The mean intensity of the 5 replicates for
each B-cell population was represented by family groups. N, naive B-cells; CB,
centroblasts; CC, centrocytes; M, memory B-cells.
Supplementary Figure 11 | Proteomic mean expression. The figure shows
clusters of proteins built by applying a hierarchical self-organizing map (SOM)
algorithm and including Gene Ontology information (molecular function and/or
subcellular location). Each protein value in each cluster corresponds to the mean
protein expression level (information collected in Supplementary Table S10,
original data in Supplementary Table S3) across the five biological replicates
analyzed per B-cell subpopulation. The figure shows how these proteins are
differently expressed in naïve (N), centroblast (CB), centrocyte (CC) and memory B-
cell (M) populations.
Supplementary Figure 12 | Comparative analysis of specific proteins
investigated by flow cytometry (FCM) and mass spectrometry (MS/MS)
approaches. The intensity values obtained with each strategy are represented in
each graphic for each evaluated protein. The gray line represents the FCM data,
whereas the orange one depicts the MS/MS results. N, naive B-cells; CB,
centroblast; CC, centrocyte; M, memory B-cell.
Supplementary File 1 | R Script for the processing and analysis of proteomic
MS/MS data and transcriptomic microarray results and their ulterior multi-omics
integration for the study of the dynamics of B-cell populations.REFERENCES
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